Delivery Order SPE2DB20D2014-SPE2DB25FC50L
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $2,259.24 and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Valtoco is a...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $405.35 to Amerisourcebergen Drug Corporation. The order is for 4561368016 units of 15 mg Valtoco nasal spray and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by June 29, 2023. Valtoco is a prescription medicine used to treat seizure clusters, also known as acute repetitive seizures. This delivery order was issued under the DLA's pharmaceutical prime vendor contract vehicle,...
- The Defense Logistics Agency awarded a delivery order valued at $2,352.92 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of July 21, 2025. This competitive delivery order utilizes firm fixed pricing and is being performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a non-set-aside procurement executed through open competition, consistent with AmerisourceBergen's established capability to meet federal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Valtoco 10 mg nasal sprays, with a firm fixed price ceiling value of $1,175.46 and a performance period ending on April 29, 2025. The award is not associated with a set-aside program and was made on April 28, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no mention...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,254.36 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp., a major pharmaceutical distributor, for the supply of 10 mg Valtoco nasal sprays. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, under which AmerisourceBergen provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has...
- The Defense Logistics Agency awarded a $1,379.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 15 mg nasal spray doses of Valtoco to treat seizures. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle and requires delivery to a facility in Conshohocken, Pennsylvania by June 26, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages the Department of Defense's global logistics...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Valtoco 15 mg nasal sprays. The fixed-price delivery order, valued at $1,080.29, has a completion date of November 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,436 to Amerisourcebergen Drug Corporation. The order is for 4561661413 units of 10 mg Valtoco nasal spray and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 2, 2023 under an indefinite delivery/indefinite quantity contract vehicle. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $1,582 firm fixed price delivery order for 4561366828 units of Valtoco 5mg nasal spray. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by June 29, 2023 in support of the DLA's medical supply chain responsibilities. No subcontractors or set aside designations were indicated. The delivery order was issued against an existing DLA...
- This firm fixed price delivery order for $405.35 was awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp for 15 mg nasal spray doses of Valtoco. The place of performance is in Conshohocken, Pennsylvania, and the period of performance is September 11-12, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, which will serve as the prime contractor in fulfilling this order for seizure treatment medications in support of...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC50LDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,226.52 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation on July 18, 2025. Valtoco is a seizure rescue medication used for acute repetitive seizure clusters, representing a specialized pharmaceutical product critical to military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, AmerisourceBergen Drug Corp serves as a prime vendor for the Defense Logistics Agency's comprehensive medical supply chain, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 7/18/25 |